Semnur Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
Semnur Pharmaceuticals, Inc. (SMNR) reported Share-based Payment Arrangement, Expense of $1.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-10
- Semnur Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $1.29M, a 988.24% increase year-over-year.
- Semnur Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.48M, a 1513.04% increase year-over-year.
- Semnur Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.03M, a 1383.21% increase year-over-year.
- Semnur Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $140.19M, a 92131.58% increase year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.29M 10-Q · filed 2026-08-10 | $2.78M 10-Q · filed 2026-08-10 | $4.81M derived: sum of 3 quarters · filed 2026-08-10 | $145.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $1.48M 10-Q · filed 2026-05-13 | $3.52M derived: sum of 2 quarters · filed 2026-05-13 | $143.71M derived: sum of 3 quarters · filed 2026-05-13 | $143.83M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $2.03M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | $142.22M derived: sum of 2 quarters · filed 2026-05-12 | $142.34M derived: sum of 3 quarters · filed 2026-08-10 | $142.44M S-1 · filed 2026-05-12 |
| 2025-09-30 | $140.19M 10-Q · filed 2025-11-12 | $140.31M derived: sum of 2 quarters · filed 2026-08-10 | $140.40M 10-Q · filed 2025-11-12 | $140.54M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $119.00K 10-Q · filed 2026-08-10 | $211.00K 10-Q · filed 2026-08-10 | $348.00K derived: sum of 3 quarters · filed 2026-08-10 | $500.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $92.00K 10-Q · filed 2026-05-13 | $229.00K derived: sum of 2 quarters · filed 2026-05-13 | $381.00K derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $137.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | $289.00K derived: sum of 2 quarters · filed 2026-05-12 | $660.00K S-1 · filed 2026-05-12 | |
| 2024-09-30 | $152.00K 10-Q · filed 2025-11-12 | $523.00K 10-Q · filed 2025-11-12 |